Two Infants Have Died After Receiving Beyfortus®

Last August, CDC recommended infants receive an injectable drug called nirsevimab — marketed under the name Beyfortus® — purportedly to prevent RSV infections. What their recommendation did not mention is that multiple infants died during clinical trials.

Parents, have you left the pediatrician’s office feeling gaslighted for raising valid concerns?

Watch a week’s worth of news on this episode of ‘This Week’ on #CHDTV 👇
https://live.childrenshealthdefense.org/chd-tv/shows/good-morning-chd/vaxxed3-mmr-fraud-and-bubonic-plague/?utm_source=rumble&utm_medium=social&utm_campaign=chdtvpromo&utm_id=20240719